As CXCL5 is one of the most upregulated factors in a pancreatic cancer mouse model with collagen I knockout, the authors proposed that this ECM alteration stimulated SOX9 transcription activation [113,115] in cancer cells [113]. This evidence concerns the gene CXCL5 and familial pancreatic carcinoma.